Sam L. Barker, Director at LEXICON PHARMACEUTICALS, INC./DE (LXRX), bought 19,000 shares at $1.58 ($30K) on 2009-10-22, disclosed to the SEC on 2009-10-26.
Open-market purchase of $30k LXRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.55 | 5,500 | $9K | 28.7% |
| 2 | $1.56 | 8,400 | $13K | 44.2% |
| 3 | $1.57 | 1,500 | $2K | 7.9% |
| 4 | $1.58 | 3,600 | $6K | 19.2% |
| Total | $1.56 avg | 19,000 | $30K | 100% |
| Filing → |
| LXRX | BUY | 2019-08-02 | $28K | — | Filing → |
| LXRX | BUY | 2017-09-18 | $13K | — | Filing → |
| CYCC | BUY | 2014-11-20 | $9K | — | Filing → |